CytoDyn
CytoDyn is developing leronlimab (PRO 140), a potential drug to treating COVID-19. Now undergoing clinical trials with the FDA.
Rankings by
National Ranking244th
in United States Regional Ranking272nd
in North America and Caribbean Global Ranking667th
worldwide